Login / Signup

Renin-angiotensin-aldosterone system blockers after KDIGO stage 3 acute kidney injury: use and impact on 2-year mortality in the AKIKI trial.

Mathilde ScartonAnne OppenheimerKhalil ChaïbiDidier DreyfussStephane Gaudry
Published in: Critical care (London, England) (2019)
Keyphrases